Dr. Aldape is a neuropathologist with a research interest in primary brain tumors. He has experience with identification of biomarkers in gliomas, including microarray studies. He has identified a mesenchymal subgroup of glioma, which may be related to microenvironmental factors. His work characterizes glioma subtypes, as well as identifies clinically relevant molecular alterations in these tumors.

Dr. Aldape is a past President of Society for Neuro-Oncology (2012-13) and serves as an Executive Editor of Neuro-Oncology.

View CV

Principal Positions Held

  • Toronto General Hospital, University of Toronto, Ontario Cancer Institute, MacFeeters-Hamilton Brain Tumor Centre, Pathology, Senior Scientist, Director, Aug 2014 - present
  • University of Toronto, Faculty of Medicine, Department of Laboratory Medicine and Pathobiology, Professor, Aug 2014-present
  • MD Anderson Cancer Center, University of Texas, Department of Pathology, Division of Pathology/Lab Medicine, Department Chair, Nov 2012-Feb 2014
  • MD Anderson Cancer Center, University of Texas, Molecular Diagnostics (Solid Tumors), Department of Pathology, Division of Pathology/Lab Medicine, Medical Director, Jan 2011-Feb 2014
  • University of Texas, School of Public Health, Epidemiology and Disease Prevention, Adjunct Professor, Houston, Texas, Jan 2009-Feb 2014
  • MD Anderson Cancer Center, University of Texas, Division of Pathology/Lab Medicine, Department of Pathology, Professor, Jan 2007-Feb 2014.
  • MD Anderson Cancer Center, University of Texas, Division of Pathology/Lab Medicine, Department of Pathology, Associate Professor, 2001-2007.
  • MD Anderson Cancer Center, University of Texas, Division of Pathology/Lab Medicine, Department of Pathology, Assistant Professor, 1995-2001.
Back to Leadership